← The SEC Ephemeris: the whole map
Adello Biologics, LLC Theragrastim.! We have completed our review of this application
In the graph: all 1 documents (12 pages).
- Application
- BLA 761082
- Ticker
- Adello Biologics, LLC
- Product
- Theragrastim.! We have completed our review of this application
- Disease area
- Not yet classified
- Response path
- Not yet classified
- Complete Response Letters
- May 10, 2018
From FDA letters and SEC filings. Not investment or medical advice.